Evaluating whether Atomera Incorporated (NASDAQ: ATOM)—a semiconductor materials and technology licensing company—is a good buy requires examining its proprietary Mears Silicon Technology and its progress in commercializing licensing deals with major chipmakers. Proponents point to the potential for transformative efficiency gains in legacy and advanced semiconductor nodes, which could yield substantial licensing royalties if widely adopted. Conversely, skeptics emphasize the historical volatility of pre-revenue or early-revenue licensing business models, lengthy industry adoption cycles, and the risk of continuous capital dilution, making it a high-risk, high-reward prospect suited primarily for speculative growth portfolios.